BRCA1 rs121912527: Understanding Pathogenic Variants
The rs121912527 variant is a rare, pathogenic genetic change located within the BRCA1 gene. It is strongly associated with an increased lifetime risk of developing hereditary breast and ovarian cancer.
What each genotype means
Typical BRCA1 genetic profile
This genotype represents the most common sequence found in the BRCA1 gene at this location. It does not carry the specific pathogenic change associated with the increased cancer risks linked to this variant. Please note that this does not eliminate the possibility of other genetic or environmental factors influencing your health.
This is the most common genotype observed in the general population across all ancestries.
Increased cancer risk carrier
This genotype indicates you carry one copy of the pathogenic variant, which is associated with an increased lifetime risk of developing breast and ovarian cancer. Because this is a hereditary condition, you should discuss these findings and appropriate screening or management strategies with a qualified healthcare provider or genetic counselor.
This genotype is rare in the general population, though its frequency can vary significantly depending on specific ancestral backgrounds.
High cancer risk profile
This genotype indicates you carry two copies of the pathogenic variant, which is strongly associated with a significantly increased lifetime risk of breast and ovarian cancer. It is essential to consult with a medical professional or genetic counselor to discuss clinical management, surveillance, and risk-reduction options tailored to your health history.
This genotype is extremely rare in the general population.
What is the rs121912527 Variant?
The rs121912527 variant is a specific alteration in the DNA sequence of the BRCA1 gene. In genomics, a variant like this represents a change from the typical sequence found in the majority of the human population. Because it is classified as pathogenic, it is known to disrupt the normal function of the gene in a way that can lead to health consequences. This variant is considered rare, meaning it is not found in the general population at high frequencies. It is typically identified through clinical genetic testing, often performed when there is a strong family history of cancer or early-onset disease. Understanding such variants requires looking at the specific location within the gene and how that change affects the protein the gene is responsible for creating.
The Role of the BRCA1 Gene
The BRCA1 gene, located on chromosome 17, provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for maintaining genomic stability by repairing damaged DNA, particularly through a process called homologous recombination. When DNA damage occurs, the BRCA1 protein helps coordinate the cellular response to fix these breaks, preventing the accumulation of mutations that could lead to uncontrolled cell growth. When a pathogenic variant is present, the cell's ability to repair its DNA is compromised. This loss of function can lead to genomic instability, which is a hallmark of cancer development. Because BRCA1 is so critical for DNA maintenance, variants that disrupt its function are closely monitored in clinical genetics.
Research and Cancer Risk
Extensive research has established that pathogenic variants in BRCA1 are strongly associated with a significantly increased lifetime risk of breast and ovarian cancer. Studies, such as those conducted by the CARRIERS consortium, have shown that carriers of these variants face a much higher probability of diagnosis compared to the general population. While the average lifetime risk for the general population is lower, individuals with a pathogenic BRCA1 variant may see their risk rise to 60% or higher by age 70. It is important to note that this risk is not 100%; not everyone who carries a pathogenic variant will develop cancer. Factors such as family history, lifestyle, and other genetic modifiers can influence the actual outcome for an individual, making genetic counseling a vital part of interpreting these results.
What You Can and Cannot Do
If you have been identified as a carrier of a pathogenic BRCA1 variant, this information is a tool for proactive health management. You cannot change your genetic code, but you can work with healthcare professionals to develop a personalized screening and prevention plan. This may include more frequent clinical breast exams, earlier or more frequent mammograms, or other imaging studies like breast MRIs. Some individuals may also discuss risk-reducing surgeries or chemoprevention options with their doctors. It is crucial to understand that this information is not a diagnosis of cancer, but rather an assessment of susceptibility. Always consult with a certified genetic counselor or an oncologist to discuss what these findings mean for your specific health situation and to avoid making medical decisions based on general information alone.
How common is this variant?
The rs121912527 variant is classified as rare in the general population, meaning it is not commonly found in large-scale genomic databases across diverse ancestries.
Frequently asked questions
Does having a BRCA1 variant mean I will get cancer?
No, having a pathogenic BRCA1 variant does not mean you will definitely develop cancer. It indicates an increased susceptibility, but many factors, including other genes and lifestyle, influence your actual risk.
How can I get tested for this variant?
Genetic testing for BRCA1 is typically ordered by a healthcare provider, such as a genetic counselor or oncologist, based on your personal or family medical history. You should discuss your concerns with a doctor to see if testing is appropriate for you.
What is the difference between a variant and a mutation?
In modern genetics, the term 'variant' is preferred to describe any change in the DNA sequence. 'Mutation' is often used to describe a variant that is known to cause a disease or disorder.
Can I change my risk if I have this variant?
While you cannot change your genetics, you can manage your risk through increased surveillance, such as more frequent cancer screenings, or by discussing risk-reduction strategies with your medical team.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912527?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
This variant is a rare genetic alteration in the BRCA1 gene, which is critical for DNA repair and associated with hereditary breast and ovarian cancer syndromes impacting reproductive health.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
This BRCA1 variant (p.Pro871Leu) is a common polymorphism often evaluated in breast cancer risk studies, though it is generally considered to have no clinical significance for hereditary breast and ovarian cancer syndrome.